Search results for "Institutional review board"

showing 1 items of 11 documents

Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma

2016

Purpose To compare whole-body MRI (WB-MRI) with diffusion-weighted imaging (DWI), FDG-PET/CT, and bone marrow biopsy (BMB), for the evaluation of bone marrow involvement (BMI) in patients with newly diagnosed lymphoma. Materials and Methods This retrospective study was approved by our Institutional Review Board. Two independent radiologists and one nuclear medicine specialist reviewed all WB-MRI and FDG-PET/CT scans prospectively performed on 104 patients with newly diagnosed lymphoma (53 males; 47 Hodgkin; mean age: 44 years; range, 15–86 years) between 2013 and 2015. The delay between imaging scans and BMBs was up to 10 days. The diagnostic accuracy of WB-MRI (1.5 Tesla MR scanner, with T…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingRetrospective cohort studyNewly diagnosedmedicine.diseaseInstitutional review board030218 nuclear medicine & medical imagingLymphoma03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureCohen's kappa030220 oncology & carcinogenesisBiopsyMedicineRadiology Nuclear Medicine and imagingBone marrowRadiologybusinessNuclear medicineJournal of Magnetic Resonance Imaging
researchProduct